
Professor of Surgery, consultant HPB surgeon, https://nitter.cf/t.co/WyZCgL59RD, #PancreaticCancer, @UofGlasgow @labspatialnbj @grisurgery @precisionpanc
Joined March 2009
- Tweets4.5K
- Following2.7K
- Followers2.2K
- Likes7.8K
Pinned Tweet
Thanks to the @erasmusuni #hpb pathology and surgical oncology team for their visit to @UofGlasgow this week
Lots of great discussion on #ColorectalCancer liver metastases growth patterns
#singlecellspatial
@UofGMVLS @LabSpatialNBJ @UofGCancerSci @DoukasMichail @grisurgery
Nigel B. Jamieson retweeted
The United States has reached out to us regarding their bases in Middle Eastern countries. We’ve also been approached by Saudi Arabia, Qatar, the United Arab Emirates, Bahrain, Jordan, and Kuwait.
We’re already working with some of them, and our expert teams are already on the ground, assessing the situation and sharing invaluable experience. Because no matter how many Patriots, THAADs, or other air defense systems are in the Middle East, that alone is not enough for fully effective air defense. There are modern interceptors designed to counter heavy drone strikes.
Now, we are discussing future deliveries of certain equipment that Ukraine has. We want Middle Eastern countries to give us the opportunity to strengthen ourselves as well. They have some air defense missiles that we lack. We would like to reach agreements on this.
Funding is the scarcest resource today. Our defense industry is currently operating at half capacity, and we need more financing to produce drones for ourselves. That’s why we are ready to sell to our partners the systems we have in surplus. And we’re not just selling – we’ll provide our expertise as well. Interceptor drones don’t work without our expertise. It’s the system that works.
From an interview with Le Monde (1/5).
Nigel B. Jamieson retweeted
Dell is reportedly cutting 14,000 people and every single CEO in America right now is looking at Claude and doing the same math.@novogratz
If I don't replace jobs with agents — I'm going to get crushed by someone who does.
That's the calculation happening in every boardroom in the country.
AI is eating white collar jobs and it's just getting started.
Here's my prediction: This becomes THE political issue of 2026 and it will absolutely dominate 2028.
What do you think the solution is? 👇🏼
Nigel B. Jamieson retweeted
After much reflection, I have decided to resign from my position as Director of the National Counterterrorism Center, effective today.
I cannot in good conscience support the ongoing war in Iran. Iran posed no imminent threat to our nation, and it is clear that we started this war due to pressure from Israel and its powerful American lobby.
It has been an honor serving under @POTUS and @DNIGabbard and leading the professionals at NCTC.
May God bless America.
Nigel B. Jamieson retweeted
Replying to @KattyKay_
@KattyKay_ said it best: Trump doesn’t want a successor — he wants a vacuum.
The mindset is simple: you were nothing before me, and you’ll be nothing after me.
Party, country, legacy — secondary. It’s all about him.
That’s not strategy, that’s psychology.
And if that sounds like a selfish child, it’s because it is.
At some point you have to stop rationalizing it and just call it what it is.
Nigel B. Jamieson retweeted
On #NationalCancerSurvivorsDay let's celebrate all the strong people who have survived and the people who have made it possible.
@nigeljamieson
@C_Roxburgh
@rho37231
@grisurgery
Ros Glasspool
And many others ❤️
Let's also remember the people who are still fighting to survive.
Cancer survivors – today is your day! It’s a time to acknowledge the victories, both big and small, and to look forward to the future with optimism and joy.
ncsd.org/today-is-national-c…
#NCSD2025 #NCSD #NationalCancerSurvivorsDay
Nigel B. Jamieson retweeted
Next step is translational analysis of serial tumour samples to understand
1. Why tumours respond more or less than others
2. how RT/anti-PDL1 impacts the TME and response evolution.
👀Watch this space @nigeljamieson @JoanneE59669325 @owen_sansom @AcrCelerate @CRUK_SI
Nigel B. Jamieson retweeted
The PRIME-RT team comprises fantastic clinical/ CTU teams from across the UK - @aberdeenuni, Oxford @TheChristieNHS, @NHSaaa and @UofGlasgow @UofGCancerSci @QUBelfast
We are especially appreciative of the patients who contributed time and energy to be part of the trial.
Nigel B. Jamieson retweeted
🇬🇧PRIME-RT results @ESTRO_RT today:
Durvalumab anti-PDL1+SC/LC TNT in #rectalcancer
52% of pts had CR (pCR/cCR) @ 6mth post-EOT in LARC
⬆️CR rate w SCRT-Durv - may reflect divergent immune effects of RT on TME
Privileged to be part of incredible ‘Top trials’ session#ESTRO25
Nigel B. Jamieson retweeted
Elderly colon cancer patients may be able to access a clinical trial that could transform future practice.
FOxTROT will test an immunotherapy drug before surgery - the first trial to test the outcomes of this approach in older patients.
More ➡️ gla.ac/433duRd
Nigel B. Jamieson retweeted
We are excited to be working with @LeedsCTRU and @JenSeligmann on the Foxtrot 5 trial. Improving options for older colon cancer patients and opening up new treatment paradigms! @UofGCancerSci
Replying to @yorkshirecancer
The FOxTROT 5 clinical trial will offer elderly people with a specific type of tumour the chance to benefit from an immunotherapy drug called 'dostarlimab' before surgery.
Treatment usually involves being given surgery first, which is sometimes followed up by chemotherapy.
Nigel B. Jamieson retweeted
The potency of abnormal genetic fusion in chronic myeloid leukaemia in our latest study @Nature 👉🏽 nature.com/articles/s41586-0… This cancer is an oddity - one of the few single genetic “hit” cancers, a short trajectory (few years) from start to diagnosis, and explosive growth.
Nigel B. Jamieson retweeted
Excited to announce our first European early access for the Pyxa platform at Dr. @NigelJamieson’s lab, @UniofGlasgow! Together, we’ll explore 3D spatial biology to advance cancer diagnostics & biomarker discovery. bit.ly/4jlYKUd
Nigel B. Jamieson retweeted
#GUTOnline paper by Kemp et al entitled
"Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression" via
bit.ly/42B7gJb
@drcolinwood @nigeljamieson @Gloerichlab #GastricCancer
Nigel B. Jamieson retweeted
Honored to present alongside experts, including our incredible MGH team, on multidisciplinary #cholangiocarcinoma management at #AHPBA2025! @curecc @FlavioRochaMD @krishnanendo @motazqadan @shimulshah73
This Post is from an account that no longer exists. Learn more
Nigel B. Jamieson retweeted
Great to see @RosenbergerMd as a world thought leader in #PhyllodesTumor, collaborating with other world experts from the Netherlands @DukeSurgOnc @DukeSurgery @DukeCancer @phyllodestumor
I am so inspired ⚡️by the steadfast advocacy by #Marco&Marloes and 🇳🇱 @phyllodestumor for the advancement of research in #PhyllodesTumors. #OnlyTogether is correct! Thank you 🙏 for visiting @DukeCancer @DukeSurgery! w/ #MichaelAiduk, @ElleHReason
Nigel B. Jamieson retweeted
Great to catch up with our European surgical
🔪 ✂️🪡 colleagues in #cholangiocarcinoma @curecc #ccfac25 🇺🇸 🇬🇧 🇳🇱 🏴 #endcancer
Nigel B. Jamieson retweeted
Happening now 🚨 Surgery Working Group 🗣️
@curecc Annual Meeting in SLC 🔪 ✂️ 🪡
Determining research priorities for:
1) Classification of resectability
2) Consideration of neoadjuvant therapy
3) Indications for liver transplantation
Nigel B. Jamieson retweeted
Published in @TheLancet, our review on #PancreaticCancer
📎Epidemiology🌎
📎Pathogenesis🔬
📎Risk factors & surveillance🕵️
📎Diagnostics🩺
📎Treatment💊
📎Future directions🔍
… by @ammar_asrar, @ObaAtsushi, T. Seufferlein, JW Wilmink, @BasGrootKoerkam & @MarcBesselink
Nigel B. Jamieson retweeted
We are so grateful to pts giving their time to participate in research @UofGlasgow at a hugely stressful time. Even more amazing when pts support research publicity interviewing for national press-Thank you Tracey!
scotsman.com/health/scotland…
glasgowtimes.co.uk/news/2504…
Nigel B. Jamieson retweeted
MASSIVE Congratulations @lily_hillson PhD on navigating her viva with NO corrections @RadNetCRUKGla @UofGCancerSci 🎉👏🥂
‘Characterising dynamic tissue and immune response to RT in #rectalcancer’
Thanks Anna Wilkins @ICR_London and @s_milling for examining. Brilliant day!







































